Galanin Has Tumor Suppressor Activity and Is Frequently Inactivated by Aberrant Promoter Methylation in Head and Neck Cancer
Authors:
- Takeharu KanazawaTKTakeharu Kanazawa
- Yuki MisawaYMYuki Misawa
- Takayuki UeharaTUTakayuki Uehara
- Atsushi ImaiAIAtsushi Imai
- Goro TakahashiGTGoro Takahashi
- Satoru TakebayashiSTSatoru Takebayashi
- Andrew ColeACAndrew Cole
- Thomas E CareyTCThomas E Carey
- Hiroyuki MinetaHMHiroyuki Mineta
Open Access
- 1 June 2013
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 6 (3) , 338-346
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 37 references indexed in Scilit:
- Synthetic Small Molecules for Epigenetic Activation of Pluripotency Genes in Mouse Embryonic FibroblastsChemBioChem, 2011
- Genotyping of 73 UM‐SCC head and neck squamous cell carcinoma cell linesHead & Neck, 2009
- Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer CellsClinical Cancer Research, 2009
- Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck CancerClinical Cancer Research, 2008
- EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal CancerJournal of Clinical Oncology, 2008
- Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2)Proceedings of the National Academy of Sciences, 2008
- Association Between Hypermethylated Tumor and Paired Surgical Margins in Head and Neck Squamous Cell CarcinomasClinical Cancer Research, 2007
- Expression of Neuropeptide Galanin and Galanin Receptors in Human SkinJournal of Investigative Dermatology, 2004
- Head and Neck CancerNew England Journal of Medicine, 1993
- Galanin — a novel biologically active peptide from porcine intestineFEBS Letters, 1983